A thorough investigation of the Muha Drug Master Case – specifically focusing on the regulatory breaches and subsequent fallout – reveals a deeply concerning pattern of misconduct. The study highlights systemic failures across multiple divisions, including quality control and documentation. It's evident that company oversight was either insuffi… Read More